Literature DB >> 23077758

Sarcosine, a biomarker for prostate cancer: ready for prime time?

Makito Miyake1, Evan Gomes Giacoia, Diego Aguilar Palacios, Charles J Rosser.   

Abstract

Entities:  

Year:  2012        PMID： 23077758

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  3 in total

1.  Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery.

Authors:  Tong Zhang; David G Watson; Lijie Wang; Muhammad Abbas; Laura Murdoch; Lisa Bashford; Imran Ahmad; Nga-Yee Lam; Anthony C F Ng; Hing Y Leung
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 2.  Sarcosine as a potential prostate cancer biomarker--a review.

Authors:  Natalia Cernei; Zbynek Heger; Jaromir Gumulec; Ondrej Zitka; Michal Masarik; Petr Babula; Tomas Eckschlager; Marie Stiborova; Rene Kizek; Vojtech Adam
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923

3.  Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia.

Authors:  Clara Pérez-Rambla; Leonor Puchades-Carrasco; María García-Flores; José Rubio-Briones; José Antonio López-Guerrero; Antonio Pineda-Lucena
Journal:  Metabolomics       Date:  2017-03-09       Impact factor: 4.290
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.